Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2024
|
Cato T Laurencin Director |
SELL
Open market or private sale
|
Direct |
2,691
-10.47%
|
$83,421
$31.85 P/Share
|
|
Dec 09
2024
|
Cato T Laurencin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,691
+9.48%
|
$59,202
$22.52 P/Share
|
|
Dec 09
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
61,151
-56.24%
|
$1,956,832
$32.07 P/Share
|
|
Dec 09
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,997
+12.15%
|
$1,077,934
$22.7 P/Share
|
|
Dec 08
2024
|
Cato T Laurencin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
958
-4.0%
|
$29,698
$31.46 P/Share
|
|
Dec 08
2024
|
Cato T Laurencin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,163
+14.8%
|
-
|
|
Dec 05
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,221
-13.37%
|
$285,851
$31.5 P/Share
|
|
Dec 04
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,349
-17.23%
|
$430,470
$30.77 P/Share
|
|
Nov 27
2024
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,208
-7.9%
|
$151,032
$29.15 P/Share
|
|
Nov 11
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
58,996
-41.46%
|
$1,769,880
$30.08 P/Share
|
|
Nov 11
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,058
+23.23%
|
$861,160
$20.03 P/Share
|
|
Nov 06
2024
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,471
-9.54%
|
$303,659
$29.53 P/Share
|
|
Aug 03
2024
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
895
-0.54%
|
$24,165
$27.72 P/Share
|
|
Aug 03
2024
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,014
+1.19%
|
-
|
|
Jun 29
2024
|
Brian P Mckeon Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-5.01%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Brian P Mckeon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+17.27%
|
-
|
|
Jun 29
2024
|
Nancy Lynn Md Snyderman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-24.0%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Nancy Lynn Md Snyderman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+50.0%
|
-
|
|
Jun 29
2024
|
Frank Anders Wilson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-5.54%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Frank Anders Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+18.74%
|
-
|
|
Jun 29
2024
|
Christopher I Wright Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-9.22%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Christopher I Wright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+27.76%
|
-
|
|
Jun 29
2024
|
David Angelo Daglio Jr. Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-5.01%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
David Angelo Daglio Jr. Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+17.27%
|
-
|
|
Jun 29
2024
|
Richard Gaynor Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-5.54%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Richard Gaynor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+18.74%
|
-
|
|
Jun 29
2024
|
Cato T Laurencin Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-6.89%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Cato T Laurencin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+22.3%
|
-
|
|
Jun 29
2024
|
Emily Peterson Alva Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,465
-5.09%
|
$35,160
$24.1 P/Share
|
|
Jun 29
2024
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+17.5%
|
-
|
|
Jun 29
2024
|
Shane Cooke Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,175
-3.08%
|
$76,200
$24.1 P/Share
|
|
Jun 29
2024
|
Shane Cooke Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,104
+5.59%
|
-
|
|
Jun 09
2024
|
Emily Peterson Alva Director |
SELL
Payment of exercise price or tax liability
|
Direct |
930
-3.94%
|
$21,390
$23.91 P/Share
|
|
Jun 09
2024
|
Emily Peterson Alva Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,871
+14.09%
|
-
|
|
Jun 08
2024
|
Christopher I Wright Director |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-7.5%
|
$18,239
$23.91 P/Share
|
|
Jun 08
2024
|
Christopher I Wright Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,301
+23.8%
|
-
|
|
Mar 18
2024
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
10,417
-13.65%
|
$291,676
$28.1 P/Share
|
|
Feb 27
2024
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Open market or private sale
|
Direct |
2,559
-24.9%
|
$74,211
$29.65 P/Share
|
|
Feb 23
2024
|
Christian Todd Nichols SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,845
-3.59%
|
$82,505
$29.57 P/Share
|
|
Feb 23
2024
|
Christian Todd Nichols SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,407
+7.49%
|
-
|
|
Feb 23
2024
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,587
-2.18%
|
$75,023
$29.57 P/Share
|
|
Feb 23
2024
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,825
+4.67%
|
-
|
|
Feb 23
2024
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-6.14%
|
$19,488
$29.57 P/Share
|
|
Feb 23
2024
|
Samuel Joseph Parisi VP, Finance (Interim PAO) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,283
+17.25%
|
-
|
|
Feb 23
2024
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,880
-2.4%
|
$112,520
$29.57 P/Share
|
|
Feb 23
2024
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,737
+5.13%
|
-
|
|
Feb 23
2024
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,811
-0.64%
|
$52,519
$29.57 P/Share
|
|
Feb 23
2024
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
4,077
+1.42%
|
-
|
|
Feb 23
2024
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,414
-2.03%
|
$99,006
$29.57 P/Share
|
|
Feb 23
2024
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,689
+4.37%
|
-
|